← Eichor
Study identifier: NCT07472400 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome

Condition: Femoroacetabular Impingement Syndrome · Healthy Participants  ·  Sponsor: University of Liege

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersYes

About this study

The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. The pathological hip of patients will be compared to their second healthy hip as well as to a healthy control group. Assessments of mobility, strength, functional tests, and questionnaire submissions will take place before the intervention and 3 and 6 months after the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Raphaël Leroy, PT, PhD candidate  ·  +32491128430  ·  rleroy@uliege.be

Always discuss trial participation with your own doctor first.

Locations (1)

Blanc Gravier sports centersSart Tilman, Liège, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07472400